NovoCure Limited (NASDAQ: NVCR) started the day on January 06, 2021, with a price decrease of -3.12% at $157.53. During the day, the stock rose to $161.37 and sunk to $154.45 before settling in for the price of $162.60 at the close. Taking a more long-term approach, NVCR posted a 52-week range of $53.40-$179.62.
It was noted that the giant of the Healthcare sector posted annual sales growth of 86.70% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 40.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.30%. This publicly-traded company’s shares outstanding now amounts to $101.23 million, simultaneously with a float of $86.71 million. The organization now has a market capitalization sitting at $16.14 billion. At the time of writing, stock’s 50-day Moving Average stood at $141.29, while the 200-day Moving Average is $94.47.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 782 workers. It has generated 449,256 per worker during the last fiscal year. Meanwhile, its income per employee was -9,246. The stock had 6.32 Receivables turnover and 0.86 Total Asset turnover. For the Profitability, stocks gross margin was +74.87, operating margin was -0.17 and Pretax Margin of -2.51.
NovoCure Limited (NVCR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Instruments & Supplies Industry. NovoCure Limited’s current insider ownership accounts for 1.60%, in contrast to 72.60% institutional ownership. According to the most recent insider trade that took place on Dec 21, this organization’s Chief Medical Officer sold 2,484 shares at the rate of 156.71, making the entire transaction reach 389,268 in total value, affecting insider ownership by 29,356. Preceding that transaction, on Dec 18, Company’s Director sold 2,500 for 166.40, making the whole transaction’s value amount to 416,000. This particular insider is now the holder of 3,400 in total.
NovoCure Limited (NVCR) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported $0.09 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.03) by $0.06. This company achieved a net margin of -2.06 while generating a return on equity of -4.38. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
NovoCure Limited’s EPS increase for this current 12-month fiscal period is 89.30% and is forecasted to reach 0.42 in the upcoming year.
NovoCure Limited (NASDAQ: NVCR) Trading Performance Indicators
Let’s observe the current performance indicators for NovoCure Limited (NVCR). It’s Quick Ratio in the last reported quarter now stands at 3.70. The Stock has managed to achieve an average true range (ATR) of 8.53. Alongside those numbers, its PE Ratio stands at $2250.43, and its Beta score is 1.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 35.89. Similarly, its price to free cash flow for trailing twelve months is now 400.43.
In the same vein, NVCR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.07, a figure that is expected to reach 0.08 in the next quarter, and analysts are predicting that it will be 0.42 at the market close of one year from today.
Technical Analysis of NovoCure Limited (NVCR)
If we take a close look at the recent performances of NovoCure Limited (NASDAQ: NVCR), its last 5-days Average volume was 0.79 million that shows plunge from its year to date volume of 0.96 million. During the previous 9 days, stock’s Stochastic %D was recorded 18.39% While, its Average True Range was 8.46.
Raw Stochastic average of NovoCure Limited (NVCR) in the period of the previous 100 days is set at 78.87%, which indicates a major rise in contrast to 13.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 46.38% that was lower than 57.82% volatility it exhibited in the past 100-days period.